SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.005-1.3%2:22 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tktrimbath who wrote (449)10/14/2005 12:57:19 PM
From: Mike McFarlandRead Replies (1) of 557
 
Saw a blurb in Businessweek about Ceregene
(Cell Genesys spinoff, has not gone public,
delivery of neurotrophic factors with AAV).

You may want to review that company--I seem
to remember that Parker in her speeches
emphasized that Tgen had a edge in producing
AAV. I could imagine some sort of a deal
where Tgen and Ceregene merge--I think the
jargon is 'reverse IPO' etc etc. Not sure that
would give you much for your tgen shares in
the short term, but for all I know Ceregene's
Parkinson therapy is genuine blockbuster
material.

Here is their PR page:
ceregene.com

Oh for crying out loud--there is that John Walker
guy again. Unbelievable, they must all golf together.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext